PROVISION OF TUMOUR PROFILING TEST

A Contract Award Notice
by NHS SOUTH WEST - ACUTES

Source
Find a Tender
Type
Contract (Supply)
Duration
not specified
Value
£122K
Sector
HEALTH
Published
26 Apr 2022
Delivery
not specified
Deadline
n/a

Concepts

Location

TORBAY HOSPITAL

Geochart for 2 buyers and 1 suppliers

2 buyers

1 supplier

Description

Nice guidelines recommend Endopredict, Oncotype DX or Prosigna Tumour profiling tests to guide adjuvant chemotherapy decisions in early breast cancer. Of these 3 tests it has been confirmed that Oncotype DX is the only one available under the framework, Contract Ref. Pathology and Point of Care Testing, Associated Equipment, Instruments, Consumables and Accessories and Managed Services (2019/S 212-519575). A direct award has been made to Exact Sciences for Oncotype DX for the following reason: Specialist expertise is required and only available from one source.

Total Quantity or Scope

Tumour profiling tests to guide adjuvant chemotherapy decisions in early breast cancer.

Award Detail

1 Exact Sciences (London)
  • PROVISION OF TUMOUR PROFILING TEST
  • Reference: loccon454
  • Num offers: 1
  • Value: £121,500

Award Criteria

NICE GUIDELINES 50.0
PRICE 50.0

CPV Codes

  • 33124130 - Diagnostic supplies

Indicators

  • Award on basis of price.

Reference

Domains